Try our Advanced Search for more refined results

Medicines Co. Gets Fed. Circ. Grilling On Blood Thinner IP

By Michael Macagnone (December 6, 2016, 3:31 PM EST) -- Members of a Federal Circuit panel questioned whether The Medicines Co. could hold onto one of its patents on the blood thinning drug Angiomax Tuesday, wondering whether the patent was so vague no one could tell whether they infringed it....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!